10X Genomics Inc is a biotechnology company focused on advancing the field of genomics through innovative technologies that enable researchers to explore biological systems at a single-cell level. The company's mission is to empower scientists to unlock the complexities of biology and disease by providing high-resolution genomic analysis tools. 10X Genomics Inc employs a strategy centered on continuous innovation and collaboration with the scientific community, offering a range of products that enhance genomic sequencing, gene expression analysis, and spatial biology. Their operations are driven by a commitment to improving human health through groundbreaking research and discoveries in genomics.

10X GENOMICS INC

10x Genomics has projected revenues between $610 million and $630 million for 2025, reflecting minimal growth amid significant uncertainties, particularly due to a potential cap on NIH funding. In its recently reported fourth-quarter earnings, the company experienced a 10% decline in revenues, with full-year 2024 revenues falling by 1% to...

10x Genomics Projects Minimal Growth Ahead Amid NIH Funding Concerns and Declining Revenues